Li L - Search Results

1

[Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].

Mao YN, Zeng LX, Li YH, Liu YZ, Wu JY, Li L, Wang Q. Mao YN, et al. Among authors: li yh, li l. Zhonghua Fu Chan Ke Za Zhi. 2017 Oct 25;52(10):687-696. doi: 10.3760/cma.j.issn.0529-567X.2017.10.008. Zhonghua Fu Chan Ke Za Zhi. 2017. PMID: 29060967 Chinese.

2

[Biological effect of down-regulating of MTRR gene on cisplatin-resistant ovarian cancer SKOV3 cells in vitro and in vivo studies].

Chen J, Wang Q, Zhang W, Li L. Chen J, et al. Among authors: li l. Zhonghua Fu Chan Ke Za Zhi. 2016 Feb;51(2):126-34. doi: 10.3760/cma.j.issn.0529-567X.2016.02.009. Zhonghua Fu Chan Ke Za Zhi. 2016. PMID: 26917482 Chinese.

3

[Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer].

Chen J, Wang Q, Zhang W, Li L. Chen J, et al. Among authors: li l. Zhonghua Fu Chan Ke Za Zhi. 2016 Apr 25;51(4):285-92. doi: 10.3760/cma.j.issn.0529-567X.2016.04.008. Zhonghua Fu Chan Ke Za Zhi. 2016. PMID: 27116987 Chinese.

4

[Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].

Wu WJ, Wang Q, Zhang W, Li L. Wu WJ, et al. Among authors: li l. Zhonghua Fu Chan Ke Za Zhi. 2016 Jul 25;51(7):515-23. doi: 10.3760/cma.j.issn.0529-567X.2016.07.007. Zhonghua Fu Chan Ke Za Zhi. 2016. PMID: 27465871 Chinese.

5

[Establishment and verification of detecting multiple biomarkers for ovarian cancer by suspension array technology].

Zhao BB, Yang ZJ, Wang Q, Pan ZM, Zhang W, Li DR, Li L. Zhao BB, et al. Among authors: li dr, li l. Zhonghua Fu Chan Ke Za Zhi. 2016 Oct 25;51(10):765-772. doi: 10.3760/cma.j.issn.0529-567X.2016.10.011. Zhonghua Fu Chan Ke Za Zhi. 2016. PMID: 27788745 Chinese.

6

[Clinical validation of multiple biomarkers suspension array technology for ovarian cancer].

Zhao BB, Yang ZJ, Wang Q, Pan ZM, Zhang W, Li L. Zhao BB, et al. Among authors: li l. Zhonghua Fu Chan Ke Za Zhi. 2017 Jan 25;52(1):11-19. doi: 10.3760/cma.j.issn.0529-567X.2017.01.005. Zhonghua Fu Chan Ke Za Zhi. 2017. PMID: 28190310 Chinese.

7

[Discrimination and clinical value of plasma metabolomic profiles in multidrug resistant epithelial ovarian cancer].

Wu WJ, Wang Q, Zhang W, Li L. Wu WJ, et al. Among authors: li l. Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):896-902. doi: 10.3760/cma.j.issn.0253-3766.2017.12.004. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 29262505 Chinese.

8

[Current status and future of epithelial ovarian cancer markers].

Li L, Yang ZJ, Wang Q. Li L, et al. Zhonghua Fu Chan Ke Za Zhi. 2017 Jan 25;52(1):4-7. doi: 10.3760/cma.j.issn.0529-567X.2017.01.003. Zhonghua Fu Chan Ke Za Zhi. 2017. PMID: 28190308 Chinese. No abstract available.

9

[Long-term clinical observation of aspheric multifocal intraocular lens implantation].

Li L, Zheng GY, Zhao YT, Li Y. Li L, et al. Among authors: li y. Zhonghua Yan Ke Za Zhi. 2017 Aug 11;53(8):599-609. doi: 10.3760/cma.j.issn.0412-4081.2017.08.008. Zhonghua Yan Ke Za Zhi. 2017. PMID: 28851201 Chinese.

10

[Bioinformatics analysis of drug-resistant ceRNA in epithelial ovarian cancer].

Pan ZM, Tan FC, Chen CX, Zhang W, Li L. Pan ZM, et al. Among authors: li l. Zhonghua Fu Chan Ke Za Zhi. 2021 Feb 25;56(2):121-130. doi: 10.3760/cma.j.cn112141-20200718-00587. Zhonghua Fu Chan Ke Za Zhi. 2021. PMID: 33631884 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99,935 results

Search Page

Filters